bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on non-invasive diagnostics and early cancer detection, today announced initiation of the Company's planned ...

Implementation and evaluation of multi-cancer early detection testing at the Dana-Farber Cancer Institute: A retrospective analysis of clinical outcomes and diagnostic pathways. Real-world analysis of ...

Lung cancer symptoms are often non-specific, leading to late detection and misattribution to less severe conditions. The GO2 for Lung Cancer provides resources, policy advocacy, and access to clinical ...

Lung cancer remains a leading cause of cancer-related mortality worldwide, highlighting the urgent need for a nuanced ...